FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation
July 14, 2014
Top Gainers Technical Data -- Research on Intrexon, Synergy Pharma, 22nd Century, and Nationstar Mortgage Holdings
May 29, 2014
Synergy Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Plecanatide in Irritable Bowel Syndrome with Constipation
July 08, 2014
Synergy Pharmaceuticals Appoints Paul Eng, Ph.D., as Senior Vice President, Drug Development
May 29, 2014
Technical Recap on Biotech Equities -- Research on Hemispherx Biopharma, Orexigen Therapeutics, Dynavax Technologies, and Synergy Pharma
May 08, 2014
Synergy Pharmaceuticals’ Chairman and CEO, Dr. Gary S. Jacob, Awarded Honorary Degree by the University of Missouri – St. Louis
May 15, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here